About This Page
This is a clinician-written, evidence-based guide aligned to the MCC Examination Objectives. It is structured by clinical presentation — the way the MCCQE tests and the way patients actually present. Management reflects current Canadian guidelines (CMA, CFPC, CPS). Always cross-reference with institutional protocols and clinical judgment.
Key points
- Quantify proteinuria with urine ACR or PCR — dipstick is a screen, not a full assessment
- Nephrotic syndrome = heavy proteinuria + hypoalbuminaemia + oedema ± hyperlipidaemia/lipiduria
- Proteinuria with hematuria, casts, hypertension, or declining eGFR suggests active glomerular disease and needs urgent nephrology assessment
- Common causes: diabetic kidney disease, hypertension, IgA nephropathy, minimal change disease, FSGS, membranous nephropathy, lupus nephritis, amyloidosis, myeloma
- Complications include venous thromboembolism, infection, AKI, dyslipidaemia, CKD progression, and medication toxicity from altered protein binding
Approach to the Presentation
Proteinuria is a marker of kidney damage and cardiovascular risk. The presentation may be incidental albuminuria on screening, foamy urine, or full nephrotic syndrome with oedema. The MCC framing most closely overlaps with generalized oedema and CKD objectives: identify renal protein loss as a cause of low oncotic pressure, determine severity, find systemic causes, and decide on nephrology referral. The central clinical question is whether this is benign/transient, chronic metabolic kidney disease, or active glomerular disease requiring urgent work-up and possible biopsy.
Differential Diagnosis
| diagnosis | likelihood | key features | distinguishing test |
|---|---|---|---|
| Rapidly progressive glomerulonephritis | must-not-miss | Proteinuria with hematuria, RBC casts, hypertension, oedema, rising creatinine, systemic vasculitis/lupus features | Urine microscopy, creatinine/eGFR, complements/ANA/ANCA/anti-GBM; urgent biopsy |
| Lupus nephritis | must-not-miss | Young patient, rash, arthritis, oral ulcers, cytopenias, hematuria/proteinuria, low complement | ANA, anti-dsDNA, C3/C4, urine ACR/PCR; renal biopsy for class |
| Membranous nephropathy / malignancy-associated nephrotic syndrome | must-not-miss | Adult nephrotic syndrome, high thrombotic risk, may be associated with malignancy, hepatitis B, autoimmune disease | PLA2R antibodies where available, serology, age-appropriate cancer evaluation, renal biopsy |
| Multiple myeloma / amyloidosis | must-not-miss | Older patient, anaemia, bone pain, hypercalcaemia, renal impairment; dipstick may miss light chains | SPEP/UPEP, serum free light chains, urine protein quantification |
| Pre-eclampsia | must-not-miss | Pregnancy/postpartum hypertension, proteinuria, headache, visual symptoms, RUQ pain, thrombocytopenia, elevated liver enzymes | BP, urine protein, CBC, creatinine, ALT/AST; obstetric assessment |
| Diabetic kidney disease | common | Longstanding diabetes, albuminuria, hypertension, retinopathy, gradual eGFR decline | Urine ACR, eGFR trend; consider alternative if active sediment or rapid decline |
| Hypertensive nephrosclerosis | common | Longstanding hypertension, mild-moderate proteinuria, LVH/vascular disease, bland urine sediment | BP history, eGFR trend, urine ACR, renal ultrasound if indicated |
| Transient/orthostatic proteinuria | common | Young person, low-grade proteinuria, normal first-morning specimen, no hematuria or renal impairment | Repeat first-morning ACR/PCR |
| Minimal change disease | less common | Abrupt nephrotic syndrome, often children but also adults; associated with NSAIDs, Hodgkin lymphoma | Renal biopsy in adults; steroid responsiveness |
| Focal segmental glomerulosclerosis | less common | Proteinuria/nephrotic syndrome, obesity, HIV, reduced nephron mass, Black ancestry risk association, progressive CKD | Renal biopsy |
Red Flags & Key History
Symptoms
Rapidly progressive oedema, oliguria, dyspnoea, or hypertension — severe glomerular disease/AKI
Hematuria, cola-coloured urine, rash, arthralgia, haemoptysis — nephritic or vasculitic process
Pregnancy with hypertension/headache/visual symptoms — pre-eclampsia
Pleuritic chest pain, unilateral leg swelling — VTE complication of nephrotic syndrome
Bone pain, weight loss, recurrent infections — myeloma/malignancy
Foamy urine and ankle swelling — proteinuria/nephrotic syndrome clue
Signs
Periorbital oedema, ascites, pleural effusion, anasarca
Severe hypertension or hypertensive emergency features
Rash/purpura, synovitis, oral ulcers — systemic inflammatory disease
Retinopathy in longstanding diabetes supports diabetic kidney disease
Approach to Investigation
First-line
Urinalysis with microscopyProtein, blood, casts, oval fat bodies/lipiduria; active sediment changes urgency
Urine ACR or PCRQuantifies albumin/protein loss and guides CKD risk/referral; first-morning specimen helps confirm persistence
Serum creatinine/eGFR, albumin, lipids, electrolytesAssess nephrotic syndrome severity, CKD, and complications
Blood pressure and diabetes assessmentBP, HbA1c/glucose, cardiovascular risk evaluation
Second-line
Serologic screenIf active sediment, nephrotic syndrome, or systemic features: complements, ANA, anti-dsDNA, ANCA, anti-GBM, hepatitis B/C, HIV
SPEP/UPEP and serum free light chainsOlder adults, anaemia, hypercalcaemia, bone pain, renal impairment, or discordant dipstick/protein quantification
Renal ultrasoundKidney size, obstruction, structural disease, chronicity clues
Specialist
Renal biopsyFor unexplained nephrotic syndrome, active sediment, rapid eGFR decline, suspected systemic GN, or atypical diabetic kidney disease
Nephrology referralUrgent if nephrotic syndrome, ACR/PCR high, active sediment, low albumin, worsening eGFR, or systemic disease
Management Principles
KDIGO 2024 CKD guidance + Canadian Society of Nephrology CKD detection/referral principles1
Initial supportive kidney protection
- Control blood pressure and reduce albuminuria when appropriate using ACEi/ARB with monitoring of creatinine and potassium
- Optimize diabetes management; consider SGLT2 inhibitor in eligible CKD/diabetes/albuminuria patients according to Canadian practice and contraindications
- Avoid NSAIDs and nephrotoxins; adjust drug doses for eGFR
2
Manage nephrotic complications
- Salt restriction and loop diuretics for oedema, balancing AKI risk
- Assess VTE risk, especially severe hypoalbuminaemia or membranous nephropathy; prophylaxis decisions are specialist-led
- Treat dyslipidaemia and infection risk; update immunizations where appropriate
3
Treat underlying cause
- Diabetic/hypertensive disease: longitudinal risk factor control and monitoring
- Immune glomerular disease: nephrology-led immunosuppression after diagnostic work-up/biopsy
- Pre-eclampsia: urgent obstetric pathway
Complications & Pitfalls
- Dipstick limitation: Dipstick mainly detects albumin and can miss light chains.
- Nephrotic thrombosis: Nephrotic syndrome is prothrombotic; sudden dyspnoea or leg swelling may be PE/DVT.
- Diabetes anchoring: Active urine sediment or rapid decline is not typical uncomplicated diabetic kidney disease.
- Over-diuresis: Aggressive diuresis can worsen intravascular depletion and AKI.
- Pregnancy: Proteinuria plus hypertension after 20 weeks is pre-eclampsia until proven otherwise.
MCCQE1 Exam Tips
- 1Proteinuria should be quantified with ACR or PCR — not just described as “dip positive”
- 2Nephrotic syndrome = heavy proteinuria + hypoalbuminaemia + oedema; add hyperlipidaemia and lipiduria as classic features
- 3Proteinuria + hematuria/RBC casts = glomerulonephritis; refer urgently
- 4Dipstick-negative renal disease in an older patient can be myeloma light-chain disease
- 5Diabetic nephropathy is gradual; rapid eGFR decline or active sediment suggests another diagnosis
- 6ACEi/ARB can reduce proteinuria but monitor creatinine and potassium
- 7Nephrotic syndrome increases VTE risk — membranous nephropathy is a classic association
Put your reading into practice
Topic-specific question practice is not linked for this article yet.
Choose MCCQE Part I questions from the existing bank. General exam practice covers your selected topics; it is not filtered to this article. Your usual question-bank access applies.
Choose MCCQE Part I practiceAfter your session, return to this section to revisit the reading and choose your next review.
Verified Sources & References
related resources
Save your place and choose what comes next
Renal & Urological · Article 18 of 36